HUE035154T2 - Piridin-4-il származékok - Google Patents

Piridin-4-il származékok Download PDF

Info

Publication number
HUE035154T2
HUE035154T2 HUE14715427A HUE14715427A HUE035154T2 HU E035154 T2 HUE035154 T2 HU E035154T2 HU E14715427 A HUE14715427 A HU E14715427A HU E14715427 A HUE14715427 A HU E14715427A HU E035154 T2 HUE035154 T2 HU E035154T2
Authority
HU
Hungary
Prior art keywords
ethyl
salt
diseases
hydroxypropyl
oxadiazol
Prior art date
Application number
HUE14715427A
Other languages
English (en)
Inventor
Martin Bolli
Cyrille Lescop
Oliver Nayler
Beat Steiner
Original Assignee
Idorsia Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idorsia Pharmaceuticals Ltd filed Critical Idorsia Pharmaceuticals Ltd
Publication of HUE035154T2 publication Critical patent/HUE035154T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/14Decongestants or antiallergics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/14Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epidemiology (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Claims (8)

  1. Sæabashbii IgdsygöÄk s ï gs < R so J «h - kept-: s/« n-n X ,\-x î k i
    en ahoi a ?<-.?;> loiben R! jelentése 2-5 szénaten-os alkil- vagy cikiopenltl-esoport; «a R; jelentése <OL'€'BíÖH}<BrNBCQ<B?úl{<3opon; vagy annak sója. ! V \ ! g \p-i.->< η s i Su b v< |x! ue ta. » f-t ! ! 'f<< Ί > p .. ni ! u > oh i<t;et í >.? î ' \ V' . *t X£H ' χ ‘ x ' t ’- ! ,!'! Ά sO\
  2. 3. Egy 1. igéoyporti szerinti vegyölét, ahol R' jelentése b-propd-, Izopropíi-, igobatE-, vagy eiklöpethli-esoperi, vagy annak sóiá.
  3. 4. Égy 1, igénypoái szerinti vegv^lek ahol E! jelentése elií lopeotlhcsopoh, vagy annak só>·
  4. 5. Egy 1-4. igénypontok bármelyike szerinti vegyi! let. ahol az -OCH,'C'lKOH)-CH?.'blKCO~CHíOl-5-csn{:ort jeientésö SV sätsreoeenvarns É-feonfignráoíójö, vagy annak sója. ó- Egy 1. igénypont szerinti vegyidét az alábbiak alleotta. csoportból választva: ί$)-Μ-(3-(2-®41~44ό-(2-οίϋρόί!Ϊίΐ>4-ϋ)-1.2,4-ο:κη4ΐΒζο1-3-Ιΐ4ό-Γηε41-ίόηοχί)-24»θΓθχ1ρΓορ11)-ζ·> Indrosiacetamid:. tS)-1443-t2-eili-4-f5--t2-pt6piipifidln-4-!l)-Lz4-oxadiazoS-3-ii)"6-n5etil'-fenoxi)-2-h;di'oxipropil)-2- Indroxiacetsood; ,\x \ '('· - -í o eeo! Ό « nőin -hi' ι'λιϊλΙ 1 ihx' v u x\' : á o\>, u',* ) 2 hidroyiaoctamid; «M-N-t.h{ ?-enl-t-i5'i?-bnolp!i'.3in"!'ih- t^4-ev3duznl-VdVb'nsetnteno\n'3-!iidros!P’Opdb3' hid on .·< : aoe · ám id ; tS)-N-(5-Í2“eSii-4-(S-i2-iztsbsáilgibóisi-é-11)-1 (;-k4-s>x3di;sz.ísi-5-sl!-5-!riebiféirox!5-2-hidrsaí<:igrop'd)-2-h-tdromeetarnkk (S>N-(3'-(2-efil-4-(3-(2-iZi'îpersb;pirâdÎ4'-4-i|fol,2>4-oxgàig:zoi'-3-5Î)-b"Snsïti1féOôXs)-2-biàs’ôxipfiipb)-3“ bifossfoaeeiasfod; (b)-1443-(2-etil-4-(3-(2-(gestáiy3 --4>(>Äi44~bH A4^XtttSaxbi«3éliHvmgtlifénbXí>24ÜáKtxi}>fópíl>'2-·» bsdroxiaeetstniid; és (8)-(4-(3-(2-ίΐϋ-4-(5-(2-éÎS{isjpeôtîÎp5?sd;8-4-îlVh2:s4-oxiîdiaKô;-3-sh-6'-5ï5çtHfti}îoxy-24iidroxîpiOpsn'-2- hldroxlacetamid; vagy ezen '/egyOäetel s<Oi<ä ? Egy 1. îgénypor»! szerinti vegyülsîf, amely {S}-N-{3<2«eiiM-{5'(2<lk)epeot}lplrldi«-4-il)-)/M’öK8djazel-3. lí)'ó-íneísífenosi)<:-h)droxípropll)-2'hidtoxlacetanísd vagy asrnak sója. x '-s' X <-pon χ , it.· 3 5kb ρ,.\ 4 t* " eié' o>. ' - a 1 /·. > :netb'ie8exi)-2-b.idi'oxípir)pií)-2-hídiOXÍiteóta5nsd vagy ssanak sbps.
  5. 8. Bgy .1-8, igénypontok bármelyiké széria ti vegytÉetét, vagy amtak gyógyászslilag elfogadható sálát, és egy gyégyáMstilsg·. elfogadható hóftfosóáhyágét tartalmazó gyógyászán tazípszzkdó. 1-gy i -2 5gei5\powb hatan, b (ke szénát, vegyidet, vagy aaoak gyógyászatiiag elfogadható sója, vagy egy 9. .-nn.onm, »zurut gxozs ϊ>,<ο, kcnpx x,o nogs,, , < ,> d»,<sfo!<x tsta
  6. 11. Egy i-§, igénypontok bármelyike szerinti vegyöfot, vagy arnsstk gyógyásgatilág «l&amp;gááháfo spps, aktíváit immusifeadszerrel öss.zeftlggó betegségek vagy rendellenességek megelőzésében vagy kezelésében való alkahn-azasre,
  7. 12. Egy 1-8. Igénypontok bármelyike szerinti vágyóiét vagy annak gyógyászai slag elfogadható sója. az alábbiak c'k'\\! evopojtbvl s ik>>>n 4 éexipegek r y,y x wik-tsc-sstes.l- ungdb <s.Jx.s rat? -v.-ele-ebs'o '.do alkalmazásra: rtanszplantáll szervek, például vese, máj, szív. tüdő, hasnyálmirigy, szasuhártya és bor fehökóíléss; óssejtálöltetós okozta graft-versas-host betegségek; autolinnsun betegségek, beleértve a. reuatatoid arídtszt sj, "<oss sts slt!5''e\.l gv! .sóssex be h<î<g.ej,.'k t met r <?5ohts betevőt' e- r <obh- uwim r ,\'ΐ·ν.’> ps/o)!4'!M)v ortnlnzt. pat'sm n.n gwlktdost m.n. a Hasban^ti tb\?e“isttti\ es uwo-tetnr szt nopa betegségek trunf a rinilisz, kötőhárrya-gynlhtdás. és atóplás. dermaiítísz; asztma; l-es íiposú diabétesz; fertőzést \'>.e> - 'ss.os 'srs > beí.^e ,es ; e s e fu - resist χ la~»t es , uv v vi'u't > e-e -»ictn îs,î es <. äs 1 s kos és tumor áttét..
  8. 13. Egy 1-8. Igénypontok bármelyike szériád vegyidet, vagy unnak gyógyászai dag el fogadható sója, az alábbiak ,il\et?a s'^'pci'b'í <5 a-'·..:;, yv!egse;,rk sutó·» .'i«'ss<gel, tcegsfo'ese'xn \ x;\ ke , t( >,foes' s,k> ,<1sî‘îi'.'< s, s'se '"η sz\es'tdc »ótrboív, aszckte's par?<ksfx \o‘ ssiokxk'se /-. , p no setes - x. graft-versus-bost betegségek; renntaloid ssiiritssz, szklerözls multiplex, psxoriázls, pszoriázisos srtrilisz, Crohn» betegség és Hashimoto thyreoidstis kóréból választod autoimmun betegségek; és atópiás demsatífisz.
HUE14715427A 2013-03-15 2014-03-14 Piridin-4-il származékok HUE035154T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13159482 2013-03-15

Publications (1)

Publication Number Publication Date
HUE035154T2 true HUE035154T2 (hu) 2018-05-02

Family

ID=47877933

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE14715427A HUE035154T2 (hu) 2013-03-15 2014-03-14 Piridin-4-il származékok

Country Status (34)

Country Link
US (1) US9617250B2 (hu)
EP (1) EP2970236B1 (hu)
JP (1) JP6387361B2 (hu)
KR (1) KR102212975B1 (hu)
CN (1) CN105189487B (hu)
AR (1) AR095523A1 (hu)
AU (1) AU2014229217B2 (hu)
BR (1) BR112015023161B1 (hu)
CA (1) CA2900910C (hu)
CL (1) CL2015002620A1 (hu)
CY (1) CY1119619T1 (hu)
DK (1) DK2970236T3 (hu)
EA (1) EA029309B1 (hu)
ES (1) ES2649475T3 (hu)
HK (1) HK1220454A1 (hu)
HR (1) HRP20171763T1 (hu)
HU (1) HUE035154T2 (hu)
IL (1) IL241363B (hu)
LT (1) LT2970236T (hu)
MA (1) MA38482B1 (hu)
MX (1) MX363545B (hu)
MY (1) MY173573A (hu)
NO (1) NO2970236T3 (hu)
NZ (1) NZ713080A (hu)
PH (1) PH12015502118A1 (hu)
PL (1) PL2970236T3 (hu)
PT (1) PT2970236T (hu)
SA (1) SA515361104B1 (hu)
SG (1) SG11201507227UA (hu)
SI (1) SI2970236T1 (hu)
TW (1) TWI623534B (hu)
UA (1) UA115357C2 (hu)
WO (1) WO2014141171A1 (hu)
ZA (1) ZA201507657B (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6437452B2 (ja) 2013-01-14 2018-12-12 インサイト・ホールディングス・コーポレイションIncyte Holdings Corporation Pimキナーゼ阻害剤として有用な二環式芳香族カルボキサミド化合物
NZ710079A (en) 2013-01-15 2020-01-31 Incyte Holdings Corp Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors
AR097431A1 (es) 2013-08-23 2016-03-16 Incyte Corp Compuestos de carboxamida de furo y tienopiridina útiles como inhibidores de quinasas pim
US9822124B2 (en) 2014-07-14 2017-11-21 Incyte Corporation Bicyclic heteroaromatic carboxamide compounds useful as Pim kinase inhibitors
US9580418B2 (en) 2014-07-14 2017-02-28 Incyte Corporation Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors
HUE047646T2 (hu) 2015-05-20 2020-05-28 Idorsia Pharmaceuticals Ltd Az (S)-3-{4-[5-(2-ciklopentil-6-metoxi-piridin-4-il)-[1,2,4]oxadiazol-3-il]-2-etil-6-metil-fenoxi} -propán-1,2-diol vegyület kristályformája
WO2016196244A1 (en) 2015-05-29 2016-12-08 Incyte Corporation Pyridineamine compounds useful as pim kinase inhibitors
WO2017004610A1 (en) * 2015-07-02 2017-01-05 Exelixis, Inc. Tercyclic s1p3-sparing, s1p1 receptor agonists
TWI734699B (zh) 2015-09-09 2021-08-01 美商英塞特公司 Pim激酶抑制劑之鹽
US9920032B2 (en) 2015-10-02 2018-03-20 Incyte Corporation Heterocyclic compounds useful as pim kinase inhibitors
AR113922A1 (es) 2017-12-08 2020-07-01 Incyte Corp Terapia de combinación de dosis baja para el tratamiento de neoplasias mieloproliferativas

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7686891A (en) 1990-04-05 1991-10-30 American National Red Cross, The A protein family related to immediate-early protein expressed by human endothelial cells during differentiation
WO1999046277A1 (en) 1998-03-09 1999-09-16 Smithkline Beecham Corporation HUMAN EDG-1c POLYNUCLEOTIDES AND POLYPEPTIDES AND METHODS OF USE
AU2003279915A1 (en) 2002-10-15 2004-05-04 Merck And Co., Inc. Process for making azetidine-3-carboxylic acid
SI2069336T1 (sl) 2006-09-07 2013-03-29 Actelion Pharmaceuticals Ltd. Derivati piridin-4-ila kot imunomodulirna sredstva
MX2009002234A (es) 2006-09-08 2009-03-16 Actelion Pharmaceuticals Ltd Derivados de piridin-3-il como agentes inmunomoduladores.
RU2442780C2 (ru) 2006-09-21 2012-02-20 Актелион Фармасьютиклз Лтд Фенильные производные и их применение в качестве иммуномодуляторов
CN101627034B (zh) 2007-03-16 2013-05-15 埃科特莱茵药品有限公司 氨基-吡啶衍生物作为s1p1/edg1受体激动剂
JP5451614B2 (ja) 2007-08-17 2014-03-26 アクテリオン ファーマシューティカルズ リミテッド S1p1/edg1受容体調節剤としてのピリジン誘導体
EA201070422A1 (ru) 2007-10-04 2010-12-30 Мерк Сероно С.А. Производные оксадиазола
KR20100092473A (ko) 2007-11-01 2010-08-20 액테리온 파마슈티칼 리미티드 신규한 피리미딘 유도체
US20110028448A1 (en) 2008-03-06 2011-02-03 Martin Bolli Pyridine compounds
CN101965346A (zh) 2008-03-06 2011-02-02 埃科特莱茵药品有限公司 新颖嘧啶-吡啶衍生物
DK2252609T3 (da) 2008-03-07 2013-06-24 Actelion Pharmaceuticals Ltd Pyridin-2-yl-derivater som immunomodulerende midler
CN102007107B (zh) 2008-03-07 2014-07-23 埃科特莱茵药品有限公司 氨甲基苯衍生物
PT2291080E (pt) * 2008-05-14 2015-10-30 Scripps Research Inst Novos modelamodeladores dos recetores da esfingosina fosfato
WO2010100142A1 (en) 2009-03-03 2010-09-10 Merck Serono S.A. Oxazole pyridine derivatives useful as s1p1 receptor agonists
PL2454255T3 (pl) 2009-07-16 2014-04-30 Idorsia Pharmaceuticals Ltd Pochodne pirydyn-4-ylowe jako agoniści S1P1/EDG1
TW201120016A (en) 2009-12-08 2011-06-16 Abbott Lab Novel oxadiazole compounds
MY163185A (en) 2011-01-19 2017-08-15 Idorsia Pharmaceuticals Ltd 2-methoxy-pyridin-4-yl derivatives

Also Published As

Publication number Publication date
NZ713080A (en) 2020-06-26
CL2015002620A1 (es) 2016-03-18
MA38482B1 (fr) 2018-11-30
KR102212975B1 (ko) 2021-02-05
ES2649475T3 (es) 2018-01-12
MX363545B (es) 2019-03-27
AR095523A1 (es) 2015-10-21
SG11201507227UA (en) 2015-10-29
HRP20171763T1 (hr) 2017-12-29
UA115357C2 (uk) 2017-10-25
CA2900910A1 (en) 2014-09-18
MY173573A (en) 2020-02-04
NO2970236T3 (hu) 2018-01-27
PH12015502118B1 (en) 2016-01-25
US20160031866A1 (en) 2016-02-04
BR112015023161A2 (pt) 2017-07-18
AU2014229217B2 (en) 2017-12-14
PL2970236T3 (pl) 2018-01-31
CY1119619T1 (el) 2018-04-04
DK2970236T3 (en) 2017-10-16
CN105189487B (zh) 2017-12-26
AU2014229217A1 (en) 2015-11-05
SI2970236T1 (sl) 2017-11-30
BR112015023161B1 (pt) 2022-11-16
LT2970236T (lt) 2017-11-10
MA38482A1 (fr) 2017-12-29
PT2970236T (pt) 2017-11-30
EP2970236A1 (en) 2016-01-20
PH12015502118A1 (en) 2016-01-25
CN105189487A (zh) 2015-12-23
BR112015023161A8 (pt) 2021-06-22
ZA201507657B (en) 2022-08-31
IL241363A0 (en) 2015-11-30
SA515361104B1 (ar) 2016-06-28
TWI623534B (zh) 2018-05-11
US9617250B2 (en) 2017-04-11
EA029309B1 (ru) 2018-03-30
TW201443044A (zh) 2014-11-16
EA201500931A1 (ru) 2016-03-31
EP2970236B1 (en) 2017-08-30
MX2015012293A (es) 2015-12-16
KR20150128947A (ko) 2015-11-18
WO2014141171A1 (en) 2014-09-18
IL241363B (en) 2018-11-29
JP6387361B2 (ja) 2018-09-05
HK1220454A1 (zh) 2017-05-05
CA2900910C (en) 2021-03-30
JP2016512227A (ja) 2016-04-25

Similar Documents

Publication Publication Date Title
DK2970236T3 (en) Pyridin-4-yl derivatives
US8658675B2 (en) Pyridin-4-yl derivatives
CA2661315C (en) Pyridin-3-yl derivatives as immunomodulating agents
WO2005123677A1 (en) 4-carbonyl substituted 1,1,2-trimethyl-1a,4,5,5a-tetrahydro-1h-4-aza-cyclopropa&#39;a!pentalene derivatives as agonists for the g-protein-coupled receptor s1p1/edg1 and immunosuppressive agents
CA2715437C (en) Pyridin-2-yl derivatives as immunomodulating agents
EP2262800A1 (en) Novel pyrimidine-pyridine derivatives